TipRanks
Go Ultimate55% OFF

Living Cell Technologies (LHI0) Financial Statements

Living Cell Technologies Financial Overview

Living Cell Technologies's market cap is currently $12.72M. The company's EPS TTM is $-0.00; its P/E ratio is -5.71; Living Cell Technologies has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 25Jun 24Jun 24Jun 22Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -557.00$ -743.00
Operating Income$ -3.14M$ -2.20M$ -1.69M$ -2.13M$ -2.38M
EBITDA$ -3.14M$ -2.10M$ -1.54M$ -2.13M$ -2.38M
Net Income$ -2.71M$ -2.10M$ -802.96K$ -2.11M$ -1.96M
Balance Sheet
Cash & Short-Term Investments$ 3.94M$ 3.11M$ 2.32M$ 6.13M$ 7.24M
Total Assets$ 4.44M$ 5.49M$ 2.40M$ 4.21M$ 4.27M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.19M$ -3.11M$ -469.22K$ -6.13M$ -7.24M
Total Liabilities$ 176.72K$ 178.45K$ 169.76K$ 449.86K$ 239.26K
Stockholders' Equity$ 4.26M$ 3.01M$ 2.23M$ 3.76M$ 4.03M
Cash Flow
Free Cash Flow$ -2.60M$ -1.52M$ -785.25K$ -1.99M$ -2.05M
Operating Cash Flow$ -2.60M$ -1.52M$ -785.25K$ -1.99M$ -2.04M
Investing Cash Flow$ 1.10M$ -277.44K$ 450.00K$ 0.00$ 39.50K
Financing Cash Flow$ 4.22M$ 523.00K$ -3.00K$ 1.85M$ 4.69M

Currency in AUD

Living Cell Technologies Earnings and Revenue History

-4M-2M02M-36000 %-24000 %-12000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Living Cell Technologies Debt to Assets

03M6M9M0 %10 %20 %30 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets

Living Cell Technologies Cash Flow

-4M-2M02M4M6M201720182019202020212022202320242025OperatingInvestingFinancing

Living Cell Technologies Forecast EPS vs Actual EPS

000000Q4 24Q2 25Q4 25Q2 26Q4 26Q2 27EPS EstimateBeatMiss